{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Neil+O%27Brien&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-07-16T15%3A40%3A11.477Z&writtenParliamentaryQuestionType=Ordinary&max-answer.questionFirstAnswered.=2024-01-24T11%3A31%3A38.74Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMember.label=Biography+information+for+Neil+O%27Brien&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-07-16T15%3A40%3A11.477Z&writtenParliamentaryQuestionType=Ordinary&max-answer.questionFirstAnswered.=2024-01-24T11%3A31%3A38.74Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Neil+O%27Brien&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-07-16T15%3A40%3A11.477Z&_metadata=all&writtenParliamentaryQuestionType=Ordinary&max-answer.questionFirstAnswered.=2024-01-24T11%3A31%3A38.74Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Neil+O%27Brien&_page=0&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-07-16T15%3A40%3A11.477Z&writtenParliamentaryQuestionType=Ordinary&max-answer.questionFirstAnswered.=2024-01-24T11%3A31%3A38.74Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Neil+O%27Brien&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-07-16T15%3A40%3A11.477Z&writtenParliamentaryQuestionType=Ordinary&max-answer.questionFirstAnswered.=2024-01-24T11%3A31%3A38.74Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Neil+O%27Brien&AnsweringBody.=Department+of+Health+and+Social+Care&min-answer.questionFirstAnswered.=2019-07-16T15%3A40%3A11.477Z&writtenParliamentaryQuestionType=Ordinary&max-answer.questionFirstAnswered.=2024-01-24T11%3A31%3A38.74Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1683149", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1683149/answer", "answerText" : {"_value" : "
Under the Public Sector Equality Duty, otherwise known as the Duty, all public authorities, including Government departments, are required by law to ensure that they have due regard to certain equality considerations when carrying out their functions. Whilst \u2018equality impact assessments\u2019 may be produced, there is no legal requirement for duty assessments to be recorded in a specific format.<\/p>
We do not centrally monitor assessments in this area but are confident that we are meeting the Duty in our decision-making processes. As a Department, we promote awareness of the Duty, via a number of channels, and the relevant analytical and other tools are available to policy professionals, to help ensure compliance with the Duty.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-01-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-01-24T11:31:38.74Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-01-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Department of Health and Social Care: Equality"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many equalities impact assessments her Department completed in each of the last five years for which data is available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "tablingMemberConstituency" : {"_value" : "Harborough"} , "tablingMemberPrinted" : [{"_value" : "Neil O'Brien"} ], "uin" : "10251"} , {"_about" : "http://data.parliament.uk/resources/1676646", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1676646/answer", "answerText" : {"_value" : "
This information is not collected centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-12-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "6038"} , {"_value" : "6039"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-12-14T16:14:27.36Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-12-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF: East Midlands"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many (a) cycles of IVF were funded and (b) people received a cycle of IVF in the Leicester, Leicestershire and Rutland integrated care board in the most recent year for which data is available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "tablingMemberConstituency" : {"_value" : "Harborough"} , "tablingMemberPrinted" : [{"_value" : "Neil O'Brien"} ], "uin" : "6037"} , {"_about" : "http://data.parliament.uk/resources/1676647", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1676647/answer", "answerText" : {"_value" : "
This information is not collected centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-12-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "6037"} , {"_value" : "6039"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-12-14T16:14:27.42Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-12-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many (a) cycles of IVF were funded and (b) people received a cycle of IVF in each NHS region in the most recent year for which data is available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "tablingMemberConstituency" : {"_value" : "Harborough"} , "tablingMemberPrinted" : [{"_value" : "Neil O'Brien"} ], "uin" : "6038"} , {"_about" : "http://data.parliament.uk/resources/1676648", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1676648/answer", "answerText" : {"_value" : "
This information is not collected centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-12-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "6037"} , {"_value" : "6038"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-12-14T16:14:27.45Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-12-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Fertility: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much the NHS spent on IVF and fertility treatment in (a) real and (b) cash terms in each year since 1997.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "tablingMemberConstituency" : {"_value" : "Harborough"} , "tablingMemberPrinted" : [{"_value" : "Neil O'Brien"} ], "uin" : "6039"} , {"_about" : "http://data.parliament.uk/resources/1670399", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1670399/answer", "answerText" : {"_value" : "
The National Institute for Health and Care Excellence (NICE) is the independent body that makes evidence-based recommendations for the National Health Service on whether medicines should be routinely funded by the NHS based on an assessment of their costs and benefits. NICE ensures that the price that the NHS pays for medicines represents value and it recommends the vast majority of medicines for use on the NHS, often as a result of commercial arrangements proposed during the NICE evaluation process. The NHS is legally required to fund medicines recommended by NICE.<\/p>
Since 2019, NHS patients have been able to access Orkambi, Symkevi and Kaftrio through an interim access agreement between NHS England, the company (Vertex), NICE, and the UK Cystic Fibrosis Trust. The agreement makes the medicines available for a limited time at a reduced price, while further information has been collected to inform a NICE appraisal. On 15 November 2023, the Medicines and Healthcare products Regulatory Agency approved a new licence extension and children as young as two years old with cystic fibrosis are now eligible to receive Kaftrio through the interim access agreement.<\/p>
NICE is currently consulting on its draft recommendations on the use of Orkambi, Symkevi and Kaftrio and has not yet published its final recommendations. NICE continues to work with stakeholders to address the issues highlighted by the committee in the draft guidance. Under the terms of the interim access agreement for the cystic fibrosis medicines, Orkambi, Symkevi and Kaftrio, eligible children and adults with cystic fibrosis can continue to receive ongoing treatment and be initiated onto treatment with these medicines, as clinically appropriate, while NICE concludes its evaluation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2023-11-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-11-22T15:41:27.047Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-11-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cystic Fibrosis: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the recommendation from NICE that modulator therapies used to treat cystic fibrosis should no longer be funded on the NHS, when she plans to make a decision on this matter: and what steps her Department is taking to ensure that life-saving treatment is made available for children with cystic fibrosis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "tablingMemberConstituency" : {"_value" : "Harborough"} , "tablingMemberPrinted" : [{"_value" : "Neil O'Brien"} ], "uin" : "2211"} , {"_about" : "http://data.parliament.uk/resources/1249528", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1249528/answer", "answerText" : {"_value" : "
The following table shows the number of finished consultant episodes (FCE) where a main or secondary procedure for gender reassignment has been recorded for each year from 2000-01 to 2019-20.<\/p>
Year<\/p><\/td> | FCEs<\/p><\/td><\/tr> | ||||||||||||
2000-01<\/p><\/td> | 87<\/p><\/td><\/tr> | ||||||||||||
2001-02<\/p><\/td> | 95<\/p><\/td><\/tr> | ||||||||||||
2002-03<\/p><\/td> | 108<\/p><\/td><\/tr> | ||||||||||||
2003-04<\/p><\/td> | 120<\/p><\/td><\/tr> | ||||||||||||
2004-05<\/p><\/td> | 135<\/p><\/td><\/tr> | ||||||||||||
2005-06<\/p><\/td> | 139<\/p><\/td><\/tr> | ||||||||||||
2006-07<\/p><\/td> | 146<\/p><\/td><\/tr> | ||||||||||||
2007-08<\/p><\/td> | 136<\/p><\/td><\/tr> | ||||||||||||
2008-09<\/p><\/td> | 168<\/p><\/td><\/tr> | ||||||||||||
2009-10<\/p><\/td> | 151<\/p><\/td><\/tr> | ||||||||||||
2010-11<\/p><\/td> | 169<\/p><\/td><\/tr> | ||||||||||||
2011-12<\/p><\/td> | 163<\/p><\/td><\/tr> | ||||||||||||
2012-13<\/p><\/td> | 167<\/p><\/td><\/tr> | ||||||||||||
2013-14<\/p><\/td> | 176<\/p><\/td><\/tr> | ||||||||||||
2014-15<\/p><\/td> | 192<\/p><\/td><\/tr> | ||||||||||||
2015-16<\/p><\/td> | 188<\/p><\/td><\/tr> | ||||||||||||
2016-17<\/p><\/td> | 204<\/p><\/td><\/tr> | ||||||||||||
2017-18<\/p><\/td> | 228<\/p><\/td><\/tr> | ||||||||||||
2018-19<\/p><\/td> | 293<\/p><\/td><\/tr> | ||||||||||||
2019-20<\/p><\/td> | 342<\/p><\/td><\/tr> | ||||||||||||
Total<\/p><\/td> | 3,407<\/p><\/td><\/tr><\/tbody><\/table> <\/p> Notes:<\/p>
|